Statin use for nonrheumatic calcific aortic valve stenosis: A review with meta-analysis

Journal of Cardiovascular Medicine

Volumn 14, Issue 8, 2013, Pages 559-567

  De Vecchis, Renato ^a   Di Biase, Giuseppina ^b   Esposito, Claudia ^c   Ciccarelli, Antonio ^d   Cioppa, Carmela ^a   Giasi, Anna ^a   Ariano, Carmelina ^b   Cantatrione, Salvatore ^a  

^a Cardiology Unit   (Italy)

^b Neurorehabilitation Unit   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Italian College of General Practitioners   (Italy)

Author keywords

Aortic valve stenosis; Meta analysis; Statins; Ultrasound assessment

Indexed keywords

EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SIMVASTATIN;

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; CALCIFICATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY DISEASE; DETERIORATION; DIABETES MELLITUS; DRUG EFFICACY; EFFECT SIZE; FOLLOW UP; HEMODYNAMICS; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESSURE GRADIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; VELOCITY;

AORTIC VALVE STENOSIS; CALCINOSIS; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; TREATMENT OUTCOME;

EID: 84880049607     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283587267     Document Type: Review

References (34)

1. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373: 956-966.
2. Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-1225. (Pubitemid 23106200)
3. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-147. (Pubitemid 29325741)
4. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001; 38:827-834. (Pubitemid 32835760)
5. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90: 844-853. (Pubitemid 24242754)
6. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19: 1218-1222. (Pubitemid 29227640)
7. Jian B, Narula N, Li QY, et al. Progression of aortic valve stenosis: TGFbeta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003; 75:457-465; discussion 465-466. (Pubitemid 36184488)
8. Kaden JJ, Dempfle CE, Grobholz R, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003; 170: 205-211. (Pubitemid 37377791)
9. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000; 101: 2497-2502. (Pubitemid 30366254)
10. Nassimiha D, Aronow WS, Ahn C, Goldman ME. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol 2001; 87: 1313-1314. (Pubitemid 32493881)
11. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611-617. (Pubitemid 30659472)
12. Kramer JR, Matsuda Y, Mulligan JC, et al. Progression of coronary atherosclerosis. Circulation 1981; 63: 519-526. (Pubitemid 11139859)
13. Hamsten A, Walldius G, Szamosi A, et al. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 1986; 73:1097-1110. (Pubitemid 16080521)
14. Anonymous. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study. Lancet 1994; 344: 633-638.
15. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. (Pubitemid 30214957)
16. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Ann Intern Med 2009; 151:W65-W94.
17. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001; 88: 693-695. (Pubitemid 32831111)
18. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001; 104: 2205-2209. (Pubitemid 33043301)
19. Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40: 1723-1730. (Pubitemid 35341948)
20. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110: 1291-1295. (Pubitemid 39202347)
21. Cowell SJ, Newby DE, Prescott RJ, et al., Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-2397. (Pubitemid 40958435)
22. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007; 49: 554-561. (Pubitemid 46177435)
23. Rossebø AB, Pedersen TR, Boman K, et al., SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-1356.
24. Mohler ER 3rd, Wang H, Medenilla E, Scott C. Effect of statin treatment on aortic valve and coronary artery calcification. J Heart Valve Dis 2007; 16: 378-386.
25. Chan KL, Teo K, Dumesnil JG, et al., ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010; 121: 306-314.
26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of diseases. J Natl Cancer Inst 1959; 22: 719-749.
27. Parolari A, Tremoli E, Cavallotti L, et al. Do statins improve outcomes and delay the progression of nonrheumatic calcific aortic stenosis? Heart 2011; 97: 523-529.
28. Teo KK, Corsi DJ, Tam JW, et al. Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebocontrolled clinical trials on 2344 patients. Can J Cardiol 2011; 27:800-808.
29. Holme I, Boman K, Brudi P, et al. Observed and predicted reduction of ischemic cardiovascular events in the simvastatin and ezetimibe in Aortic Stenosis trial. Am J Cardiol 2010; 105: 1802-1808.
30. Ge H, Zhang Q, Wang BY, He B. Therapeutic effect of statin on aortic stenosis: a review with meta-analysis. J Clin Pharm Ther 2010; 35:385-393.
31. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989; 13: 545-550. (Pubitemid 19073920)
32. Faggiano P, Ghizzoni G, Sorgato A, et al. Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 1992; 70: 229-233.
33. Roger VL, Tajik AJ, Bailey KR, et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J 1990; 119: 331-338. (Pubitemid 20064498)
34. Rosenhek R, Klaar U, SchemperM, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004; 25: 199-205. (Pubitemid 38235155)